BIOMAT Database Logo BIOMAT Database Logo

[A case of multiple myeloma presenting myeloma cells in cerebrospinal fluid]. 1983

H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001536 Bence Jones Protein An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA. Bence Jones Protein Den,Bence Jones Protein SUT,Jones Protein, Bence,Protein, Bence Jones

Related Publications

H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
[Abnormal cerebrospinal fluid plasma cells in a case of myeloma].
April 1986, No to shinkei = Brain and nerve,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
CEREBROSPINAL FLUID PARAPROTEINS IN MULTIPLE MYELOMA.
August 1965, The Journal of laboratory and clinical medicine,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
Dividing plasma cells in the cerebrospinal fluid of a patient with refractory multiple myeloma.
October 2015, Blood,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
[Dissemination of multiple myeloma through the cerebrospinal fluid].
January 1960, Neurologia, neurochirurgia i psychiatria polska,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
[Myeloma cells in cerebrospinal fluid (author's transl)].
January 1973, Zeitschrift fur Neurologie,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
Total protein content of cerebrospinal fluid in multiple myeloma.
May 1953, Neurology,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma.
August 2020, HemaSphere,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
[Cerebrospinal fluid changes in multiple myeloma. Review of the literature and report of a case].
September 1982, Arquivos de neuro-psiquiatria,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenström's macroglobulinemia.
November 1983, Neurology,
H Sao, and H Yoshikawa, and T Murayama, and Y Akao, and A Hiraiwa, and S Takagi, and T Yamauchi, and S Yoshikawa
Multiple myeloma presenting as stridor: A case report.
January 2006, Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India,
Copied contents to your clipboard!